title: [The observation of clinical efficacy of combined modality therapy in 58 cases of perennial allergic rhinitis].
abstract: OBJECTIVE
  To study the effect of combined modality therapy on perennial allergic rhinitis (PAR).
  
  
  METHODS
  Fifty-eight cases of PAR received a 4-weeks treatment with combined beclomethasone dipropionate nasal spray (BDP), cetirizine hydrochloride, ethmoidal nerve radiofrequency treatment, and half-dose combined BDP, cetirizine hydrochlonde was used for improving the recurrence symptoms in one year follow-up.
  
  
  RESULTS
  The overall effective (excellent/good) rate was 94.83% (excellent 72.41%, good 22.41%). The recurrence rate was 51.72%, but symptoms of 27 recurrence cases were lighter than pre-treatment. All treatments were well tolerated, and no serious adverse events occurred.
  
  
  CONCLUSIONS
  The reasonable combined modality therapy is aimed at the complicated pathogenesis of PAR, and the curative effect is satisfactory, so it is a good way to treat PAR.
authors.affiliation: Department of Otolaryngology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021.
authors.forename: Qiutian
authors.initials: Q
authors.lastname: Lu
authors.forename: Jianping
authors.initials: J
authors.lastname: Liang
authors.forename: Bei
authors.initials: B
authors.lastname: Liu
authors.forename: Yangda
authors.initials: Y
authors.lastname: Qin
mesh_terms: D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D001507:Beclomethasone / Q000008:administration & dosage; D017115:Catheter Ablation; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*
chemical_list: D001507:Beclomethasone